Search Result "genotype-4."
Outcomes of Treatment and Predictors of Response to Sofosbuvir Plus Simeprevir in Hepatitis C Virus with Genotype-4 Infection
Journal: Infectious Disorders - Drug Targets
Volume: 20 Issue: 3 Year: 2020 Page: 389-395
Author(s): Ossama A. Ahmed,Mohamed A Elsebaey,Mohamed Hassan A. Fouad,Mahmoud Elkadeem,Rehab Badawi,Ahmed Khayyal,Shaimaa Soliman,Manal Saad Negm,Sherief Abd-Elsalam
Potent Inhibitory Effects of p7 Inhibitors on Genotype 4 HCV-infected Peripheral Blood Mononuclear Cells
Journal: Recent Patents on Biomarkers
Volume: 2 Issue: 3 Year: 2012 Page: 227-233
Author(s): Maged A. Saleh,Radwa Y. Mekky,Nada El-Ekiaby,Nabila Hamdi,Rasha Ahmed,Abdel Rahman Zekri,Gamal Esmat,Ahmed I. Abdelaziz
Ledipasvir/Sofosbuvir versus Daclatasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype 4 Patients
Journal: Current Drug Safety
Volume: 15 Issue: 1 Year: 2020 Page: 53-60
Author(s): Lamiaa N. Abdelaty,Ahmed A. Elnaggar,Amira A. Said,Raghda R.S. Hussein
Disturbed Sleep Patterns in Elders with Mild Cognitive Impairment: The Role of Memory Decline and ApoE ε 4 Genotype
Journal: Current Alzheimer Research
Volume: 9 Issue: 3 Year: 2012 Page: 290-297
Author(s): Eva Hita-Yanez,Mercedes Atienza,Eulogio Gil-Neciga,Jose L. Cantero
Comparative Real Life Egyptian Experience of the Combination of SofosbuvirPlus Daclatasvir or Simeprevir for 12 Weeks in Naïve Cirrhotic PatientsInfected with HCV Genotype 4
Journal: Current Drug Safety
Volume: 18 Issue: 2 Year: 2023 Page: 207-213
Author(s):
Cytotoxic T Lymphocyte Antigen 4 Gene +49 A/G (rs231775) Polymorphism and Susceptibility to Systemic Lupus Erythematosus
Journal: Current Rheumatology Reviews
Volume: 17 Issue: 2 Year: 2021 Page: 247-251
Author(s): Rania Mohammed Kishk,Maii Abdelraheem Abdellatif,Raghda Elsawi Eldesouki,Mohamed Fawzy,Shaymaa Abdelraheem Abdelhady,Marwa Mohamed Fouad
Genetic Polymorphisms of CYP2D6: Prevalence in Healthy Kurds
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 17 Issue: 1 Year: 2020 Page: 40-47
Author(s): Muslih Abdulkarim Ibrahim,Zalina Zahari,Nurfadhlina Musa,Khoo Boon Yin
Deciphering the Significance of Plasma Chemokines as PrognosticBiomarkers in Pegylated IFN-Î-2a /Ribavirin-Treated Chronic HepatitisC Genotype 4 Patients
Journal: Infectious Disorders - Drug Targets
Volume: 22 Issue: 5 Year: 2022 Page: 58-62
Author(s): M. Haroon Hamed,Peter Natesan Pushparaj
Predictability of Sustained Virological Response to Pegylated Interferon Alpha-2b Plus Ribavirin Therapy by Week-8 Viral Response in HIVPositive Patients with Chronic Hepatitis C Virus Infection
Journal: Current HIV Research
Volume: 7 Issue: 4 Year: 2009 Page: 447-455
Author(s): E. Angeli, A. Mainini, A. Cargnel, C. Uberti-Foppa, A. Orani, R. Carbone, M. Andreoni, M. Schiavini, R. Giorgi, G. Rizzardini, G. Gubertini
Cytochrome P450 2A6 Phenotyping Based on Dietary Caffeine Intake in a Japanese Population of Non-smokers
Journal: Drug Metabolism Letters
Volume: 6 Issue: 2 Year: 2012 Page: 67-72
Author(s): Miyuki Kimura,Makiko Shimizu,Kazuma Kiyotani,Kazuko Nakagawa,Tetsuya Kamataki,Hiroshi Yamazaki